dactinomycin and Granulomatous Disease, Chronic

dactinomycin has been researched along with Granulomatous Disease, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bersani, L; Colotta, F; Lazzarin, A; Mantovani, A; Poli, G	1

Other Studies

1 other study(ies) available for dactinomycin and Granulomatous Disease, Chronic

Article	Year
Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors. Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:5 Topics: Adolescent; Adult; Animals; Catalase; Cell Line; Cytotoxicity, Immunologic; Dactinomycin; Female; Free Radicals; Granulomatous Disease, Chronic; Humans; Immunosuppressive Agents; Isoflurophate; Male; Monocytes; Oxygen; Phenylmethylsulfonyl Fluoride; Protease Inhibitors; Sarcoma, Experimental; Superoxide Dismutase	1985

Article

Year

Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.

Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:5

Topics: Adolescent; Adult; Animals; Catalase; Cell Line; Cytotoxicity, Immunologic; Dactinomycin; Female; Free Radicals; Granulomatous Disease, Chronic; Humans; Immunosuppressive Agents; Isoflurophate; Male; Monocytes; Oxygen; Phenylmethylsulfonyl Fluoride; Protease Inhibitors; Sarcoma, Experimental; Superoxide Dismutase

1985